Pharmacokinetics of codeine and its metabolites in Caucasian healthy volunteers: comparisons between extensive and poor hydroxylators of debrisoquine.

作者: QY Yue , J. Hasselstrom , JO Svensson , J. Sawe

DOI: 10.1111/J.1365-2125.1991.TB05585.X

关键词:

摘要: 1. The kinetics of codeine and seven its metabolites codeine-6-glucuronide (C6G), norcodeine (NC), NC-glucuronide (NCG), morphine (M), M-3 (M3G) 6-glucuronides (M6G), normorphine (NM) were investigated after a single oral dose 50 mg phosphate in 14 healthy Caucasian subjects including eight extensive (EM) six poor (PM) hydroxylators debrisoquine. plasma urine concentrations the measured by h.p.l.c. 2. mean area under curve (AUC), half-life total clearance 1020 +/- 340 nmol l-1 h, 2.58 0.57 h 2.02 0.73 l h-1 kg-1, respectively. There no significant differences between EM PM these aspects. 3. had significantly lower AUC M3G, active M6G, NM M (P less than 0.0001), partial metabolic O-demethylation 0.0001). In contrast, higher NC 0.05) EM. was difference C6G NCG, nor clearances N-demethylation glucuronidation. 4. Among EM, 15 times that codeine, which turn M. AUCs M6G about 6 10 M, glucuronidation 8 12 those N- O-demethylations, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)

参考文章(38)
John W. A. Findlay, Evelyn C. Jones, Robert F. Butz, Richard M. Welch, Plasma codeine and morphine concentrations after therapeutic oral doses of codeine-containing analgesics Clinical Pharmacology & Therapeutics. ,vol. 24, pp. 60- 68 ,(1978) , 10.1002/CPT197824160
Hidetoshi Yoshimura, Seiu Îda, Kazuta Oguri, Hisao Tsukamoto, Biochemical basis for analgesic activity of morphine-6-glucuronide—I: Penetration of morphine-6-glucuronide in the brain of rats Biochemical Pharmacology. ,vol. 22, pp. 1423- 1430 ,(1973) , 10.1016/0006-2952(73)90320-1
De Kornfeld Tj, Lasagna L, ANALGESIC POTENCY OF NORMORPHINE IN PATIENTS WITH POSTOPERATIVE PAIN Journal of Pharmacology and Experimental Therapeutics. ,vol. 124, pp. 260- 263 ,(1958)
C.W. Hand, W.P. Blunnie, L.P. Claffey, A.J. Mcshane, H.J. Mcquay, R.A. Moore, POTENTIAL ANALGESIC CONTRIBUTION FROM MORPHINE-6-GLUCURONIDE IN CSF The Lancet. ,vol. 330, pp. 1207- 1208 ,(1987) , 10.1016/S0140-6736(87)91341-9
KYOICHI SHIMOMURA, OSAMU KAMATA, SHOWA UEKI, SEIU IDA, KAZUTA OGURI, HIDETOSHI YOSHIMURA, HISAO TSUKAMOTO, Analgesic Effect of Morphine Glucuronides Tohoku Journal of Experimental Medicine. ,vol. 105, pp. 45- 52 ,(1971) , 10.1620/TJEM.105.45
J. Desmeules, M.-P. Gascon, P. Dayer, M. Magistris, Impact of environmental and genetic factors on codeine analgesia. European Journal of Clinical Pharmacology. ,vol. 41, pp. 23- 26 ,(1991) , 10.1007/BF00280101
J Sawe, L Kager, JO Svensson Eng, A Rane, Oral morphine in cancer patients: in vivo kinetics and in vitro hepatic glucuronidation. British Journal of Clinical Pharmacology. ,vol. 19, pp. 495- 501 ,(1985) , 10.1111/J.1365-2125.1985.TB02675.X
Pierre Dayer, Jules Desmeules, Thierry Leemann, Rita Striberni, Bioactivation of the narcotic drug codeine in human liver is mediated by the polymorphic monooxygenase catalyzing debrisoquine 4-hydroxylation (cytochrome P-450 dbl/bufI) Biochemical and Biophysical Research Communications. ,vol. 152, pp. 411- 416 ,(1988) , 10.1016/S0006-291X(88)80729-0